论文部分内容阅读
近年来，研究表明，血清载脂蛋白APOA、APOB高密度脂蛋白胆固醇（HDL－C），低密度脂蛋白胆固醇（LDL－C）已作为预测和制定冠心病、动脉粥样硬化的风险因素指标。肾脏病患者并发心血管疾病出现了明显的上升趋势，而对这方面的致病因素探讨不多。因此，我们对不伴并发症的肾脏
In recent years, studies have shown that serum apolipoprotein APOA, APOB HDL-C and LDL-C have been used as risk factors in predicting and setting coronary heart disease and atherosclerosis . There is a clear upward trend of cardiovascular disease in patients with kidney disease, but little is known about the pathogenic factors in this area. Therefore, we do not have complications with the kidneys